Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of 119.50 billion. The enterprise value is 137.43 billion.
| Market Cap | 119.50B |
| Enterprise Value | 137.43B |
Important Dates
The next estimated earnings date is Thursday, January 30, 2025.
| Earnings Date | Jan 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.05% |
| Shares Change (QoQ) | -0.46% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.10B |
Valuation Ratios
The trailing PE ratio is 23.78.
| PE Ratio | 23.78 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 23.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 27.35 |
| EV / Sales | 2.73 |
| EV / EBITDA | 10.39 |
| EV / EBIT | 14.86 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 1.86 |
| Debt / FCF | n/a |
| Interest Coverage | 12.99 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 5.88% |
| Revenue Per Employee | 627,636 |
| Profits Per Employee | 58,378 |
| Employee Count | 86,088 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.89% in the last 52 weeks. The beta is 0.42, so Sanofi's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -4.89% |
| 50-Day Moving Average | 99.91 |
| 200-Day Moving Average | 101.25 |
| Relative Strength Index (RSI) | 42.43 |
| Average Volume (20 Days) | 1,393 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of 54.03 billion and earned 5.03 billion in profits. Earnings per share was 4.00.
| Revenue | 54.03B |
| Gross Profit | 37.34B |
| Operating Income | 10.00B |
| Pretax Income | 6.76B |
| Net Income | 5.03B |
| EBITDA | 13.94B |
| EBIT | 10.00B |
| Earnings Per Share (EPS) | 4.00 |
Balance Sheet
The company has 7.58 billion in cash and 26.49 billion in debt, giving a net cash position of -18.91 billion.
| Cash & Cash Equivalents | 7.58B |
| Total Debt | 26.49B |
| Net Cash | -18.91B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 81.42B |
| Book Value Per Share | 64.80 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 69.12%, with operating and profit margins of 18.50% and 9.30%.
| Gross Margin | 69.12% |
| Operating Margin | 18.50% |
| Pretax Margin | 12.50% |
| Profit Margin | 9.30% |
| EBITDA Margin | 25.81% |
| EBIT Margin | 18.50% |
| FCF Margin | n/a |
Dividends & Yields
Sanofi does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.05% |
| Shareholder Yield | 0.05% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |